MiR-204-5p may regulate oxidative stress in myopia

Bo Jiang,Nan Hong,Dongyu Guo,Jianqin Shen,Xilin Qian,Feng Dong
DOI: https://doi.org/10.1038/s41598-024-60688-1
IF: 4.6
2024-04-30
Scientific Reports
Abstract:The mechanisms underlying myopia remain not fully understood. We proposed to examine the function and underlying mechanisms of miR-204-5p in myopia development. The miR-204-5p expression level was assessed in the vitreous humor (VH) of a cohort consisting of 11 patients with high myopia (HM) and 16 control patients undergoing vitrectomy. Then the functional implications of miR-204-5p in ARPE-19 cells were assessed. Thioredoxin-interacting protein (TXNIP) was found as a possible target of miR-204-5p through mRNA sequencing, and its interaction with miR-204-5p was confirmed employing luciferase assay and western blotting. Furthermore, the miR-204-5p function in regulating oxidative stress was examined by measuring reactive oxygen species (ROS) accumulation. The results indicated a significant reduction of miR-204-5p in the VH of HM patients. Overexpression of miR-204-5p suppressed cell proliferation, migration, invasion, and apoptosis in ARPE-19 cells. The direct targeting of miR-204-5p on TXNIP has been confirmed, and its downregulation mediated the miR-204-5p impacts on ARPE-19 cells. Moreover, miR-204-5p overexpression significantly reduced ROS accumulation by targeting TXNIP. Our findings revealed the possible contribution of the miR-204-5p/TXNIP axis in myopia development by regulating oxidative stress, which may provide new targets to combat this prevalent and debilitating condition.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the function of miR - 204 - 5p in the development of myopia and its underlying mechanisms. Specifically, the researchers hope to understand how miR - 204 - 5p affects the development of myopia by regulating oxidative stress. The paper mentions that although the mechanism of myopia has not been fully understood, previous studies have shown that epigenetic modification plays an important role in the development of myopia. Among them, microRNAs (miRNAs), as key molecules in gene expression regulation, their abnormal expression is associated with a variety of diseases. Therefore, this study aims to evaluate the expression level of miR - 204 - 5p in the vitreous humor of high - myopia patients and further explore its function in retinal pigment epithelial cells (ARPE - 19 cells), especially its role in regulating oxidative stress by targeting thioredoxin - interacting protein (TXNIP). The main findings of the study include: 1. **The expression of miR - 204 - 5p in the vitreous humor of high - myopia patients is significantly decreased**: Through qPCR detection, it was found that the expression level of miR - 204 - 5p in the vitreous humor of high - myopia patients was significantly lower than that in the control group. 2. **Over - expression of miR - 204 - 5p inhibits the proliferation, migration, invasion and apoptosis of ARPE - 19 cells**: By transfecting miR - 204 - 5p mimics, the study found that over - expression of miR - 204 - 5p significantly inhibited the proliferation, migration and invasion abilities of ARPE - 19 cells and reduced cell apoptosis. 3. **miR - 204 - 5p directly targets TXNIP**: Through mRNA sequencing and dual - luciferase reporter gene assay, TXNIP was confirmed as a direct target of miR - 204 - 5p. 4. **miR - 204 - 5p reduces oxidative stress by down - regulating TXNIP**: The study found that over - expression of miR - 204 - 5p significantly reduced the accumulation of reactive oxygen species (ROS) and promoted the expression of NRF2 protein, while over - expression of TXNIP reversed these effects. These results indicate that miR - 204 - 5p may regulate oxidative stress by targeting TXNIP, thus playing an important role in the development of myopia. This finding not only enhances the understanding of the pathogenesis of myopia, but also provides a potential target for the development of new treatment strategies.